Incannex Healthcare (IXHL) Interest Expenses (2023 - 2026)
Incannex Healthcare (IXHL) posted quarterly Interest Expenses of $123000.0 for Q1 2026, down 61.32% year-on-year from $318000.0 in Q1 2025, and down 30.11% on a QoQ basis from $176000.0 in Q4 2025.
Incannex Healthcare (IXHL) Interest Expenses (2023 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Interest Expenses for 4 consecutive years, with $123000.0 the latest figure, recorded in Q1 2026.
- Quarterly Interest Expenses fell 61.32% year-over-year to $123000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123000.0 (down 61.32% YoY) and the FY2025 annual result came in at $303000.0, down 99.82% from the prior year.
- Interest Expenses fell to $123000.0 in Q1 2026 per IXHL's latest filing, from $176000.0 in the prior quarter.
- Over the last five years, Interest Expenses for IXHL reached as high as $171.9 million in Q2 2024 and fell as low as $123000.0 in Q1 2026.
- A 4-year average of $15.9 million and a median of $363000.0 in 2024 frame the typical range for Interest Expenses.
- Annual changes were most pronounced in 2024 — Interest Expenses surged 115254.36% — and 2026, when it tumbled 61.32%.
- Year by year, Interest Expenses stood at $609000.0 in 2023, then sank by 40.39% to $363000.0 in 2024, then plunged by 51.52% to $176000.0 in 2025, then tumbled by 30.11% to $123000.0 in 2026.
- According to Business Quant data, Interest Expenses over the past three periods registered $123000.0, $176000.0, and $227000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 62.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 944.51 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 1.77 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 2.17 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 1.21 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 590.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 123,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 123,000.00 |
| Mar 31, 2026 | 123,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Dec 31, 2025 | 176,000.00 |
| Sep 30, 2025 | 227,000.00 |
| Sep 30, 2025 | 227,000.00 |
| Mar 31, 2025 | 318,000.00 |
| Mar 31, 2025 | 318,000.00 |
| Dec 31, 2024 | 363,000.00 |
| Dec 31, 2024 | 363,000.00 |
| Sep 30, 2024 | 458,000.00 |
| Sep 30, 2024 | 458,000.00 |
| Jun 30, 2024 | 171.88 Mn |
| Jun 30, 2024 | 171.88 Mn |
| Mar 31, 2024 | 534,000.00 |
| Mar 31, 2024 | 534,000.00 |
| Dec 31, 2023 | 609,000.00 |
| Dec 31, 2023 | 609,000.00 |
| Sep 30, 2023 | 442,000.00 |
| Sep 30, 2023 | 442,000.00 |